SCYNEXIS, Inc. Total Contract Liability
SCYNEXIS, Inc. (SCYX) had Total Contract Liability of $664.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-03-12
- 2024-12-31: Contract with Customer, Liability $664.00K.
- 2024-09-30: Contract with Customer, Liability $1.43M.
- 2024-06-30: Contract with Customer, Liability $1.49M.
- 2024-03-31: Contract with Customer, Liability $1.62M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2024-12-31 | $664.00K 10-K · filed 2025-03-12 |
| 2024-09-30 | $1.43M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.49M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.62M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.06M 10-K · filed 2025-03-12 |
| 2023-09-30 | $4.75M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $3.25M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $1.86M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $1.54M 10-K · filed 2025-03-12 |
| 2022-09-30 | $1.84M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $1.72M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $1.59M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $1.38M 10-K · filed 2024-03-28 |
| 2021-09-30 | $1.49M 10-Q · filed 2021-11-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |